Stocks · Health care · Pharmaceutical Preparations

LEXICON PHARMACEUTICALS, INC.

LXRX Clue Score48
United States Fiscal year ends December CIK 0001062822
$1.68 -4.55% Close, 9 Oct 2026

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
1.68 on 9 Oct 2026
3 2 1 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $1.44 14 Oct 2025 $1.46 15 Oct 2025 $1.53 16 Oct 2025 $1.47 17 Oct 2025 $1.42 20 Oct 2025 $1.52 21 Oct 2025 $1.44 22 Oct 2025 $1.39 23 Oct 2025 $1.40 24 Oct 2025 $1.42 27 Oct 2025 $1.39 28 Oct 2025 $1.37 29 Oct 2025 $1.33 30 Oct 2025 $1.34 31 Oct 2025 $1.38 3 Nov 2025 $1.36 4 Nov 2025 $1.33 5 Nov 2025 $1.38 6 Nov 2025 $1.43 7 Nov 2025 $1.25 10 Nov 2025 $1.42 11 Nov 2025 $1.56 12 Nov 2025 $1.54 13 Nov 2025 $1.44 14 Nov 2025 $1.49 17 Nov 2025 $1.46 18 Nov 2025 $1.47 19 Nov 2025 $1.45 20 Nov 2025 $1.32 21 Nov 2025 $1.34 24 Nov 2025 $1.42 25 Nov 2025 $1.41 26 Nov 2025 $1.43 28 Nov 2025 $1.43 1 Dec 2025 $1.36 2 Dec 2025 $1.34 3 Dec 2025 $1.40 4 Dec 2025 $1.42 5 Dec 2025 $1.40 8 Dec 2025 $1.39 9 Dec 2025 $1.31 10 Dec 2025 $1.32 11 Dec 2025 $1.32 12 Dec 2025 $1.30 15 Dec 2025 $1.23 16 Dec 2025 $1.20 17 Dec 2025 $1.15 18 Dec 2025 $1.18 19 Dec 2025 $1.17 22 Dec 2025 $1.22 23 Dec 2025 $1.21 24 Dec 2025 $1.23 26 Dec 2025 $1.23 29 Dec 2025 $1.17 30 Dec 2025 $1.15 31 Dec 2025 $1.15 2 Jan 2026 $1.14 5 Jan 2026 $1.14 6 Jan 2026 $1.14 7 Jan 2026 $1.17 8 Jan 2026 $1.18 9 Jan 2026 $1.17 12 Jan 2026 $1.18 13 Jan 2026 $1.20 14 Jan 2026 $1.24 15 Jan 2026 $1.28 16 Jan 2026 $1.37 20 Jan 2026 $1.31 21 Jan 2026 $1.56 22 Jan 2026 $1.76 23 Jan 2026 $1.70 26 Jan 2026 $1.57 27 Jan 2026 $1.71 28 Jan 2026 $1.50 29 Jan 2026 $1.44 30 Jan 2026 $1.16 2 Feb 2026 $1.25 3 Feb 2026 $1.28 4 Feb 2026 $1.27 5 Feb 2026 $1.18 6 Feb 2026 $1.23 9 Feb 2026 $1.20 10 Feb 2026 $1.31 11 Feb 2026 $1.37 12 Feb 2026 $1.31 13 Feb 2026 $1.31 17 Feb 2026 $1.32 18 Feb 2026 $1.32 19 Feb 2026 $1.52 20 Feb 2026 $1.47 23 Feb 2026 $1.51 24 Feb 2026 $1.48 25 Feb 2026 $1.50 26 Feb 2026 $1.50 27 Feb 2026 $1.47 2 Mar 2026 $1.56 3 Mar 2026 $1.61 4 Mar 2026 $1.63 5 Mar 2026 $1.64 6 Mar 2026 $1.71 9 Mar 2026 $1.68 10 Mar 2026 $1.66 11 Mar 2026 $1.72 12 Mar 2026 $1.72 13 Mar 2026 $1.69 16 Mar 2026 $1.61 17 Mar 2026 $1.62 18 Mar 2026 $1.56 19 Mar 2026 $1.62 20 Mar 2026 $1.56 23 Mar 2026 $1.64 24 Mar 2026 $1.72 25 Mar 2026 $1.68 26 Mar 2026 $1.63 27 Mar 2026 $1.65 30 Mar 2026 $1.51 31 Mar 2026 $1.56 1 Apr 2026 $1.64 2 Apr 2026 $1.59 6 Apr 2026 $1.59 7 Apr 2026 $1.60 8 Apr 2026 $1.67 9 Apr 2026 $1.76 10 Apr 2026 $1.72 13 Apr 2026 $1.71 14 Apr 2026 $1.75 15 Apr 2026 $1.86 16 Apr 2026 $1.84 17 Apr 2026 $1.87 20 Apr 2026 $1.84 21 Apr 2026 $1.83 22 Apr 2026 $1.82 23 Apr 2026 $1.68 24 Apr 2026 $1.68 27 Apr 2026 $1.69 28 Apr 2026 $1.66 29 Apr 2026 $1.55 30 Apr 2026 $1.61 1 May 2026 $1.63 4 May 2026 $1.60 5 May 2026 $1.65 6 May 2026 $1.60 7 May 2026 $1.68 8 May 2026 $2.00 11 May 2026 $2.31 12 May 2026 $2.41 13 May 2026 $2.44 14 May 2026 $2.33 15 May 2026 $2.23 18 May 2026 $2.14 19 May 2026 $2.13 20 May 2026 $2.21 21 May 2026 $2.23 22 May 2026 $2.16 26 May 2026 $2.06 27 May 2026 $2.17 28 May 2026 $2.21 29 May 2026 $2.18 1 Jun 2026 $2.07 2 Jun 2026 $1.89 3 Jun 2026 $1.85 4 Jun 2026 $1.90 5 Jun 2026 $1.91 8 Jun 2026 $1.88 9 Jun 2026 $1.88 10 Jun 2026 $1.88 11 Jun 2026 $1.89 12 Jun 2026 $1.92 15 Jun 2026 $1.96 16 Jun 2026 $1.95 17 Jun 2026 $2.04 18 Jun 2026 $2.01 22 Jun 2026 $2.15 23 Jun 2026 $2.16 24 Jun 2026 $2.22 25 Jun 2026 $2.29 26 Jun 2026 $2.55 29 Jun 2026 $2.64 30 Jun 2026 $2.40 1 Jul 2026 $2.34 2 Jul 2026 $2.32 6 Jul 2026 $2.32 7 Jul 2026 $2.37 8 Jul 2026 $2.27 9 Jul 2026 $2.25 10 Jul 2026 $2.22 13 Jul 2026 $2.17 14 Jul 2026 $2.12 15 Jul 2026 $2.20 16 Jul 2026 $2.24 17 Jul 2026 $2.39 20 Jul 2026 $2.33 21 Jul 2026 $2.38 22 Jul 2026 $2.25 23 Jul 2026 $2.30 24 Jul 2026 $2.29 27 Jul 2026 $2.23 28 Jul 2026 $2.34 29 Jul 2026 $2.32 30 Jul 2026 $2.34 31 Jul 2026 $2.31 3 Aug 2026 $2.33 4 Aug 2026 $2.49 5 Aug 2026 $2.45 6 Aug 2026 $2.36 7 Aug 2026 $2.47 10 Aug 2026 $2.40 11 Aug 2026 $2.43 12 Aug 2026 $2.35 13 Aug 2026 $2.34 14 Aug 2026 $2.32 17 Aug 2026 $2.34 18 Aug 2026 $2.42 19 Aug 2026 $2.41 20 Aug 2026 $2.18 21 Aug 2026 $2.30 24 Aug 2026 $2.32 25 Aug 2026 $2.34 26 Aug 2026 $2.31 27 Aug 2026 $2.32 28 Aug 2026 $2.29 31 Aug 2026 $2.25 1 Sep 2026 $2.19 2 Sep 2026 $2.24 3 Sep 2026 $2.26 4 Sep 2026 $2.24 8 Sep 2026 $2.23 9 Sep 2026 $2.15 10 Sep 2026 $2.02 11 Sep 2026 $2.00 14 Sep 2026 $1.98 15 Sep 2026 $2.01 16 Sep 2026 $2.02 17 Sep 2026 $2.04 18 Sep 2026 $2.05 21 Sep 2026 $2.04 22 Sep 2026 $2.18 23 Sep 2026 $2.06 24 Sep 2026 $1.86 25 Sep 2026 $1.80 28 Sep 2026 $1.90 29 Sep 2026 $1.88 30 Sep 2026 $1.88 1 Oct 2026 $1.82 2 Oct 2026 $1.82 5 Oct 2026 $1.74 6 Oct 2026 $1.75 7 Oct 2026 $1.76 8 Oct 2026 $1.76 9 Oct 2026 $1.68 Invus Global Management, LLC Director Bought $2.00M 2 Feb 2026 · at $1.30 DEBBANE RAYMOND Director Bought $75.88K 13 Feb 2026 · at $1.31 · 4.2% of stake DEBBANE RAYMOND Director Bought $100.54K 17 Feb 2026 · at $1.31 · 5.3% of stake DEBBANE RAYMOND Director Bought $176.47K 18 Feb 2026 · at $1.32 · 8.8% of stake DEBBANE RAYMOND Director Bought $71.97K 19 Feb 2026 · at $1.44 · 3.0% of stake DEBBANE RAYMOND Director Bought $147.79K 20 Feb 2026 · at $1.48 · 5.9% of stake DEBBANE RAYMOND Director Bought $147.00K 23 Feb 2026 · at $1.47 · 5.5% of stake DEBBANE RAYMOND Director Bought $2.98K 25 Feb 2026 · at $1.49 · 0.1% of stake
8 buys0 sales at will0 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$49.80M
Net income
$50.34M
Free cash flow
$67.85M
Operating margin
-98.2%
Net margin
-101.1%
Return on equity
-46.8%
Return on capital
-23.9%
Debt to equity
0.50
Revenue growth, 1 yr
729.9%
Revenue growth, 5 yr
16.3% a year

Revenue and profit

Fiscal years, as filed with the SEC · point at a year for the detail
Full statements →
23M -59M FY20 Fiscal year 2020 Revenue $23.40M Net income $58.57M Margin -250.3% 0K -88M FY21 Fiscal year 2021 Revenue $0.00 Net income $87.76M Margin n/a · growth -100.0% 0K -102M FY22 Fiscal year 2022 Revenue $0.00 Net income $101.94M Margin n/a 1M -177M FY23 Fiscal year 2023 Revenue $1.11M Net income $177.12M Margin -15,956.7% 6M -200M FY24 Fiscal year 2024 Revenue $6.00M Net income $200.40M Margin -3,339.5% · growth +440.6% 50M -50M FY25 Fiscal year 2025 Revenue $49.80M Net income $50.34M Margin -101.1% · growth +729.9%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
25 Feb 2026 DEBBANE RAYMOND
Director
Bought $2.98K 0.1%
23 Feb 2026 DEBBANE RAYMOND
Director
Bought $147.00K 5.5%
20 Feb 2026 DEBBANE RAYMOND
Director
Bought $147.79K 5.9%
19 Feb 2026 DEBBANE RAYMOND
Director
Bought $71.97K 3.0%
18 Feb 2026 DEBBANE RAYMOND
Director
Bought $176.47K 8.8%
17 Feb 2026 DEBBANE RAYMOND
Director
Bought $100.54K 5.3%